top of page

FOUNDING TEAM

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque leo mauris, pretium et ipsum quis, convallis ullamcorper sem. Maecenas elementum nibh nisi, eu auctor nunc pulvinar vitae. Donec ut interdum leo. Nam ac felis semper, facilisis nulla venenatis, molestie nibh.

FOUNDING TEAM

PD Dr. Andrea Chicca

Project leader/senior scientist at UniBern.

2 years in pharma industry.

8 years of research activity on the ECS

Prof. Dr. Jürg Gertsch

Full Professor at UniBern.
Collaboration with pharma industry.
10+ years of research activity on the ECS.

July 2023 // Communication

Sarah Farcy
Jul 18, 2023
1 min read

Synendos Therapeutics AG announces that co-founder and Scientific Advisor Board member, Professor Jürg Gertsch, presented groundbreaking new findings on an endocannabinoid transporter at the 10th Gordon Research Conference - Monday the 17th 2023 at 07h00 PM.

Prof. Jürg Gertsch, provided for the first time new insights into the novel transport mechanism that influences the balance of the endocannabinoid system, identifying and characterising the biological machinery responsible for endocannabinoid cell reuptake.

Synendos investigates the therapeutic potential of this novel mode of action and Prof. Gertsch's pioneering research forms the basis of Synendos’ approach.